The Medicines and Health products Regulatory Agency (MHRA) has issued a class two medicines recall for Oxylan 40mg prolonged-release tablets of GL Pharma.
GL Pharma is recalling the below batch of the tablets due to out of specification results for dissolution obtained during routine stability testing.
Product Details
Oxylan 40mg prolonged-release tablets, PL 21597/0064Active pharmaceutical ingredient: Oxycodone Hydrochloride
| Batch Number | Expiry Date | Pack Size | First Distributed |
|---|---|---|---|
| 9F119A | 31/05/2024 | 56 | 02/06/2020 |
The healthcare professionals have been adviced to stop supplying the batch immediately and remove it from the shelves within the pharmacy.
It has also been suggested to quarantine all remaining stock and return it to the supplier using approved process.
